• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2500021 特立帕肽注射液 teriparatide Injection Biological Products(3.3) Supplementary Application 2025-01-22 Suzhou Genemen Biotech Co Ltd view
JTH2400172 特立帕肽注射液 teriparatide Injection Chemical Drugs Disposable Import Drug Application 2024-10-11 Shanghai Ambio Inc;Ambio Pharma Europe;Novocol Pharmaceutical of Canada Inc view
CXSL2400506 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2024-08-01 Shanghai Duomirui Biotechnology Co Ltd view
JYSB2400162 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2024-07-18 Lilly France;Eli Lilly Nederland BV view
JYSZ2400027 特立帕肽注射液 teriparatide Injection Biological Products License Renew 2024-05-17 Lilly France;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
CXHL2400319 特立帕肽注射液 teriparatide Injection Chemical Drugs(2.2) New Drug Application 2024-03-29 Yunnan Xianshi Pharmaceutical Co Ltd view
CXHS2400015 特立帕肽注射液 teriparatide Injection Chemical Drugs(2.2) New Drug Application 2024-02-23 Hybio Pharmaceutical Co Ltd view
CXSL2300676 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2023-10-09 Shanghai Duomirui Biotechnology Co Ltd view
CXSS2200073 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2022-08-16 Wuxi Hebang Bio-Tech Co Ltd view
CXSS2200068 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2022-07-19 Shanghai United Cell Biotechnology Co Ltd view
CXSS2200062 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2022-06-29 Beijing Genetech Pharmaceutical Co Ltd view
JYSB2200082 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2022-05-10 Lilly France;Eli Lilly Nederland BV view
JXSL2101143 特立帕肽注射液 teriparatide Injection Biological Products(3.3) Import Drug Application 2021-12-02 Alvogen Inc view
JTS2100540 特立帕肽注射液 teriparatide Injection Biological Products Disposable Import Drug Application 2021-10-27 Eli Lilly & Co (Taiwan) Inc;Lilly France;Shanghai United Cell Biotechnology Co Ltd view
CXSS2100011 特立帕肽注射液 teriparatide Injection Biological Products(3.3) New Drug Application 2021-01-19 信立泰(苏州)药业有限公司 Suzhou Genemen Biotech Co Ltd In Review 2021-01-19 view
JYSB2000385 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2020-08-21 Eli Lilly Nederland B.V. Eli Lilly Nederland BV;Lilly France Filed 2020-09-02 view
CXSL2000194 特立帕肽注射液 teriparatide Injection Biological Products(15) New Drug Application 2020-07-07 无锡和邦生物科技有限公司 Wuxi Hebang Bio-Tech Co Ltd In Review 2020-07-06 view
CXSL2000138 重组人特立帕肽注射液 teriparatide Injection Biological Products(15) New Drug Application 2020-06-20 北京博康健基因科技有限公司 Beijing Genetech Pharmaceutical Co Ltd In Review 2020-06-19 view
JYSB2000245 特立帕肽注射液 teriparatide Injection Biological Products Supplementary Application 2020-06-19 Eli Lilly Nederland B.V. Eli Lilly Nederland BV;Lilly France Filed 2020-06-22 view
CXSL2000065 特立帕肽注射液 teriparatide Injection Biological Products(15) New Drug Application 2020-04-10 信立泰(苏州)药业有限公司 Suzhou Genemen Biotech Co Ltd;Shenzhen Salubris Pharmaceuticals Co Ltd;Chengdu Jinkai Biotech Co Ltd In Review 2020-04-09 view